Reuters: Regulatory News: BRIEF-GSK,Theravance announce regulatory submission for Anoro Ellipta in Japan

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

BRIEF-GSK,Theravance announce regulatory submission for Anoro Ellipta in Japan Apr 22nd 2013, 09:07 LONDON, April 22 | Mon Apr 22, 2013 5:07am EDT LONDON, April 22 (Reuters) - GlaxoSmithKline Plc : * GSK and Theravance announce regulatory submission for Anoro Ellipta (UMEC/Vi) in Japan * Intends to commence global regulatory submissions for UMEC monotherapy later

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions